Alcentra Capital enters into review process to evaluate strategic alternatives
Alcentra Capital Corporation announced that its board of directors has entered into a formal review process to evaluate strategic alternatives for the company. The board of directors has authorized its Committee of Independent Directors to lead the process. The board of directors has not set a timetable for the conclusion of the strategic alternatives review. There can be no assurance that the review will result in a transaction or change the company's announced strategy. The company does not intend to comment further regarding the review unless or until it determines that further disclosure is appropriate or required by law. The Committee of Independent Directors has engaged Houlihan Lokey as its financial advisor. In light of the strategic alternatives review, the company expects to hold its 2019 annual meeting of stockholders in the fourth quarter of 2019.